Chargement en cours...
Agonist antibodies for cancer immunotherapy: History, Hopes and Challenges
Immunotherapy is amongst the most promising new treatment modalities to arise over the last two decades; antibody drugs are delivering immunotherapy to millions of patients with many different types of cancer. Initial success with antibody therapeutics came in the form of direct targeting or cytotox...
Enregistré dans:
| Publié dans: | Clin Cancer Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2024
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615925/ https://ncbi.nlm.nih.gov/pubmed/38153346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-23-1014 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|